 |
|
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
Hye-Kyung Cho
Clin Exp Pediatr. 2021;64(9):459-467. Published online 2021 Feb 10 DOI: https://doi.org/10.3345/cep.2020.01305
|
|
Citations to this article as recorded by
 The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
Maodong Leng, Junmei Yang, Juanjuan Zhou
Frontiers in Pediatrics.2023;[Epub] CrossRef Investigating the occurrence of autoimmune diseases among children and adolescents hospitalized for Mycoplasma pneumoniae infections
Eun Kyo Ha, Ju Hee Kim, Hye Ryeong Cha, Bo Eun Han, Youn Ho Shin, Hey-Sung Baek, Sun Hee Choi, Man Yong Han
Frontiers in Immunology.2023;[Epub] CrossRef Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
Yun Jung Choi, Eun Hee Chung, Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yoojung Cho, Ju-Hee Seo, In Suk Sol, Myongsoon Sung, Dae Jin Song, Young Min Ahn, Hea Lin Oh, Jinho Yu, Sungsu Jung, Kyung Suk Lee, Ju Suk Lee
Journal of Clinical Medicine.2022; 11(2): 306. CrossRef Association of children wheezing diseases with meteorological and environmental factors in Suzhou, China
Jia-qi Huang, Jin Zhang, Chuang-li Hao, Zheng-rong Chen
Scientific Reports.2022;[Epub] CrossRef Efficacy of Gamma Globulin Combined with Azithromycin Sequential Therapy in the Treatment of RMPP and Its Effect on Th1/Th2 Cytokine Levels
Jie Qi, Fang Jia, Hui Tian, Shengmei Yang, Pan Zheng
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
|